Android app Apple app link

Praxis Precision Medicines, Inc. (PRAX) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$291.36
Day's range
$327.54

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
08/17/2026 Raymond James Tiago Fauth $945.00 $366.81   157.63%
08/07/2026 RBC Capital Leonid Timashev $462.00 $363.81   26.99%
08/07/2026 Wells Fargo Benjamin Burnett $362.00 $370.16   -2.2%
06/29/2026 Needham Ami Fadia $575.00 $329.52   74.5%
06/17/2026 RBC Capital Leonid Timashev $449.00 $270.01   66.29%
06/02/2026 Oppenheimer Jay Olson $650.00 $335.16   93.94%
06/02/2026 BTIG Kambiz Yazdi $810.00 $335.16   141.68%
06/02/2026 Deutsche Bank David Hoang $374.00 $335.16   11.59%
05/26/2026 H.C. Wainwright Douglas Tsao $1,245.00 $348.00   257.76%
01/05/2026 Needham Ami Fadia $460.00 $286.40   60.61%
12/15/2025 Oppenheimer Jay Olson $750.00 $268.69   179.13%
12/09/2025 Guggenheim Yatin Suneja $760.00 $270.98   180.46%
12/08/2025 BTIG Kambiz Yazdi $507.00 $247.99   104.44%
12/05/2025 Piper Sandler Yasmeen Rahimi $450.00 $253.01   77.86%
12/05/2025 Needham Ami Fadia $304.00 $255.76   18.86%
11/06/2025 Guggenheim Yatin Suneja $540.00 $172.35   213.32%
10/16/2025 Jefferies Andrew Tsai $300.00 $175.76   70.69%
06/02/2025 Oppenheimer Jay Olson $97.00 $39.82   143.6%
09/04/2024 H.C. Wainwright Douglas Tsao $120.00 $29.25   310.26%
09/04/2024 Needham Ami Fadia $151.00 $29.25   416.24%
09/03/2024 Oppenheimer Francois Brisebois $143.00 $27.83   413.83%
09/03/2024 Truist Financial Joon Lee $150.00 $27.08   453.91%
08/14/2024 Needham Ami Fadia $145.00 $25.73   463.54%
08/14/2024 Guggenheim Yatin Suneja $170.00 $26.25   547.62%
08/05/2024 Oppenheimer Francois Brisebois $134.00 $26.93   397.59%
05/28/2024 Jefferies Kambiz Yazdi $141.00 $22.13   537.14%
03/26/2024 Jefferies Kambiz Yazdi $128.00 $31.28   309.21%

Praxis Precision Medicines Inc FAQ's

Praxis Precision Medicines Inc has been rated by research analysts at Goldman Sachs, Raymond James, RBC Capital, Robert W. Baird, Wells Fargo, Needham in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.